We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Wants Prompt PSPs to Bring Earlier Waivers/Dismissals
PhRMA Wants Prompt PSPs to Bring Earlier Waivers/Dismissals
September 20, 2013
Drugmakers that submit Pediatric Study Plans (PSPs) early in the drug development process should be rewarded by the FDA with early decisions on the proposals, allowing them to begin product development more quickly than their counterparts that wait until later, PhRMA believes.